Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostacyclin mimetics with non-prostanoid structures]

K Kondo1, N Hamanaka

  • 1Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.

Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|September 1, 1995
PubMed
Summary

Researchers developed novel hydronaphthalene derivatives that act as prostacyclin agonists. One compound, ONO-AP-500-02, uniquely inhibits thromboxane synthase, offering potential for new drug development targeting prostanoid receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nematocidal activity of long alkyl chain amides, amines, and their derivatives on dog roundworm larvae.

Chemical & pharmaceutical bulletin·1992
Same author

Regulation of proliferation by vasopressin in aortic smooth muscle cells: function of protein kinase C.

Journal of hypertension·1992
Same author

Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.

Japanese journal of cancer research : Gann·1992
Same author

[A report of a case of esophageal achalasia with rapid development].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1992
Same author

[Effect of acute ethanol administration on lipid composition of rat liver plasma membrane and serum--with two different doses of ethanol].

Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence·1992
Same author

Structure of the Drosophila melanogaster gene encoding cyclin A.

Gene·1992

Area of Science:

  • Medicinal Chemistry
  • Pharmacology

Context:

  • Prostanoids are crucial signaling molecules involved in various physiological processes.
  • Developing selective receptor modulators is key for therapeutic intervention.
  • Existing therapies often lack specificity, leading to side effects.

Purpose:

  • To develop novel receptor binding assays for prostanoids.
  • To identify and synthesize compounds that interact with prostanoid receptors.
  • To explore the potential of hydronaphthalene derivatives as therapeutic agents.

Summary:

  • Hydronaphthalene derivatives were synthesized and tested for prostanoid receptor interaction.
  • Pure prostacyclin agonists (ONO-AP-227, ONO-AP-437) and a dual-action compound (ONO-AP-500-02) were identified.

Related Experiment Videos

  • ONO-AP-500-02 demonstrated specific IP receptor binding and inhibited thromboxane synthase.
  • These compounds effectively inhibited platelet aggregation in vitro and in vivo.

    • Impact:

    • Demonstrates the potential of rational drug design for creating selective prostanoid receptor modulators.
    • Highlights the possibility of developing compounds with combined pharmacological actions, such as prostacyclin agonism and thromboxane synthase inhibition.
    • Suggests a pathway for discovering new drug candidates for conditions involving prostanoid signaling and platelet aggregation.